Hot Product

TZcheck CK-MB Rapid Test for Pharmacy Use Rapid Testing

Short Description:

The CK-MB Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human CK-MB in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).

Place of Origin:China
Brand name:TZcheck

Certification:CE


Product Detail

Product Tags

The TZcheck CK-MB Rapid Test from Tongzhou Biotechnology redefines the standards for quick and accurate diagnostics in pharmacy settings. Designed specifically for pharmacy use rapid testing, this rapid test provides timely and precise measurements of CK-MB levels, an important biomarker for cardiac events. Whether you're a pharmacist aiming to deliver immediate diagnostic support or a healthcare professional in need of reliable onsite cardiac testing, the TZcheck CK-MB Rapid Test is your go-to solution.

CK-MB Rapid Test


Cat. No.

C003-4002

Product Description

CK-MB Rapid Test

Specimen

WB/S/P

Format

Cassette

Kit Size

10 T

Cut-Off

5 ng/mL

Status

CE

Creatine Kinase MB (CK-MB) is an enzyme present in the cardiac muscle with a molecular weight of 87.0 kDa. Creatine Kinase is a dimeric molecule formed from two subunits designated as “M” and “B” which combine to form three different isoenzymes, CK-MM, CK-BB, and CK-MB. CK-MB is the isoenzyme of Creatine Kinase most involved in the metabolism of cardiac muscle tissue.

The release of CK-MB into the blood following MI can be detected within 3-8 hours after the onset of symptoms. It peaks within 9 to 30 hours, and returns to baseline levels within 48 to 72 hours. CK-MB is one of the most important cardiac markers and is widely recognized as the traditional marker for the diagnosis of MI.

The CK-MB Rapid Test (Whole Blood/Serum/Plasma) is a simple test that utilizes a combination of antibody coated particles and capture reagents to qualitatively detect CK-MB in whole blood, serum or plasma. The minimum detection level is 5 ng/mL CK-MB.



Combining cutting-edge technology with user-friendly design, the TZcheck CK-MB Rapid Test offers unparalleled reliability and ease of use. Its sensitive detection mechanism ensures that even the slightest elevations in CK-MB levels are detected promptly, allowing for early intervention and improved patient outcomes. This makes it an indispensable tool in any pharmacy setting, where timely health assessments can significantly influence treatment choices and patient care strategies. Moreover, the TZcheck CK-MB Rapid Test is designed with the pharmacy professional in mind. Its simple, one-step procedure minimizes the chance for errors, ensuring that even staff members new to rapid testing can perform the test efficiently and accurately. The test’s compact packaging and straightforward instructions mean it’s easy to store and quick to deploy, enabling pharmacies to offer rapid testing services without disrupting their workflow. In summary, the TZcheck CK-MB Rapid Test is not just a product but a pivotal component in enhancing the diagnostic capabilities within your pharmacy, ensuring you’re always prepared to meet your patients’ needs swiftly and effectively.

  • Previous:
  • Next:
  • Leave Your Message